Monday, October 13, 2025

Medipharm Labs CFO Resigns From Company For Family Reasons

Medipharm Labs (TSX: LABS) this morning announced changes to their leadership team within a brief news release that was issued. The company has revealed that current chief financial officer Robert (Bobby) Kwon has resigned from the company just barely a year after taking on the role.

Appointed to the position last November, Kwon effectively took over the role on November 18, 2019. At the time, he was hyped as being a highly experienced executive from the consumer packaged goods, retail and pharmaceutical industries with over twenty five years of experience.

Kwon is said to be leaving for family reasons, with his official departure taking place at the end of the month. An interim CFO is expected to fulfill the role until a permanent replacement can be found, with the search beginning immediately. Neither an interim or permanent replacement was named in this mornings announcement.

A further announcement with respect to the interim appointee is expected to be made at the end of the month.

Medipharm Labs last traded at $0.78 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

First Majestic Posts Record Quarterly Silver Production In Q3

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

Related News

MediPharm Labs Revenues Increase 37.8% to $43.38 Million

Medipharm Labs (TSX: LABS) announced third quarter earnings this morning, posting revenues of $43.38 million...

Tuesday, November 12, 2019, 08:44:55 AM

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM

Medipharm Labs Revenues Crater 64.5% Quarter Over Quarter To $4.9 Million

It appears that not all operators are able to successfully perform under the changing market...

Monday, November 16, 2020, 08:01:12 AM

Medipharm Labs Launches Self-Branded Line Of Products

Medipharm Labs (TSX: LABS) is launching its first branded products to the Canadian marketplace. This...

Thursday, March 26, 2020, 08:33:37 AM

Medipharm Signs Danish White Label Agreement

Medipharm Labs (TSX: LABS) continues to expand its international presence, this morning announcing that it...

Friday, September 25, 2020, 08:49:28 AM